Article thumbnail

Identification of structural aberrations in cancer by SNP array analysis

By Stefan Heinrichs and A Thomas Look

Abstract

SNP microarrays are a powerful way of uncovering mutations relevant to cancer

Topics: Minireview
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2323212
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2004). Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.
  2. (2007). Analysis and Visualization of Gene Expression
  3. (2004). C: dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics
  4. (2005). Chromosome 1p and 11q deletions and outcome in neuroblastoma.
  5. (1998). CJ: The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature
  6. (2002). et al.: The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.
  7. (2006). Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.
  8. (2004). GB: Molecular therapeutics: promise and challenges. Semin Oncol
  9. (2002). Gene expression profiling predicts clinical outcome of breast cancer.
  10. (2002). Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell
  11. (2007). Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays. PLoS ONE
  12. (2007). Genomewide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature
  13. (2005). Genomewide single nucleotide polymorphism microarray mapping in basal cell carcinomas unveils uniparental disomy as a key somatic event. Cancer Res
  14. (2006). Global variation in copy number in the human genome. Nature
  15. (1998). High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet
  16. (2006). Inferring loss-ofheterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays. PLoS Comput Biol
  17. (2005). Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature
  18. (2007). Ivanova E, Perna I, et al.: Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature
  19. (2005). Look AT: Molecular genetics of acute lymphoblastic leukemia.
  20. (2005). Making progress through molecular attacks on cancer. Cold Spring Harb Symp Quant Biol
  21. (2007). MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science
  22. (1999). Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science
  23. (1997). Oncogenic transcription factors in the human acute leukemias. Science
  24. (2005). Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants. PLoS Med
  25. (2007). Pax5: the guardian of B cell identity and function. Nat Immunol
  26. (2005). PP: Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression. Genes Dev